Foresite Capital Management III as of Dec. 31, 2015
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 18 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 20.0 | $23M | 1.4M | 15.95 | |
| Global Blood Therapeutics In | 13.2 | $15M | 460k | 32.33 | |
| Alder Biopharmaceuticals | 6.7 | $7.6M | 230k | 33.03 | |
| Epizyme | 6.6 | $7.4M | 462k | 16.02 | |
| Acceleron Pharma | 6.5 | $7.3M | 150k | 48.75 | |
| Zafgen | 6.1 | $6.9M | 1.1M | 6.29 | |
| Aimmune Therapeutics | 5.8 | $6.6M | 355k | 18.45 | |
| Regulus Therapeutics | 5.6 | $6.3M | 719k | 8.72 | |
| Aerie Pharmaceuticals | 5.0 | $5.7M | 233k | 24.35 | |
| Orexigen Therapeutics | 4.6 | $5.2M | 3.0M | 1.72 | |
| Intersect Ent | 4.0 | $4.5M | 200k | 22.50 | |
| Neuroderm Ltd F | 4.0 | $4.5M | 262k | 17.05 | |
| Lipocine | 3.8 | $4.3M | 330k | 12.93 | |
| Akari Therapeutics | 3.4 | $3.8M | 264k | 14.50 | |
| Dyax | 1.9 | $2.1M | 56k | 37.62 | |
| Regenxbio Inc equity us cm (RGNX) | 1.5 | $1.7M | 100k | 16.60 | |
| Dimension Therapeutics | 1.0 | $1.1M | 98k | 11.28 | |
| ImmunoGen | 0.5 | $581k | 43k | 13.57 |
